|
SEPHS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.320440E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.377300E-04 |
| Normal-vs-Stage2 |
2.838300E-04 |
| Normal-vs-Stage3 |
6.675700E-02 |
| Normal-vs-Stage4 |
6.262400E-03 |
| Stage1-vs-Stage2 |
1.338950E-01 |
| Stage1-vs-Stage3 |
8.891800E-01 |
| Stage1-vs-Stage4 |
3.705000E-01 |
| Stage2-vs-Stage3 |
3.696600E-01 |
| Stage2-vs-Stage4 |
8.590200E-01 |
| Stage3-vs-Stage4 |
4.559200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.91299999999983E-05 |
| Normal-vs-AfricanAmerican |
9.869800E-01 |
| Normal-vs-Asian |
1.489430E-01 |
| Caucasian-vs-AfricanAmerican |
3.402800E-01 |
| Caucasian-vs-Asian |
5.975400E-01 |
| AfricanAmerican-vs-Asian |
2.602400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.078500E-02 |
| Normal-vs-Female |
1.187890E-02 |
| Male-vs-Female |
6.487400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.591360E-04 |
| Normal-vs-Extreme_Weight |
2.558900E-03 |
| Normal-vs-Obese |
3.023600E-02 |
| Normal-vs-Extreme_Obese |
1.075970E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.119200E-01 |
| Normal_Weight-vs-Obese |
1.096040E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.229200E-01 |
| Extreme_Weight-vs-Obese |
4.624200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.811400E-01 |
| Obese-vs-Extreme_Obese |
5.538200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.463560E-01 |
| Normal-vs-Age(41-60Yrs) |
9.448600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.12670000054871E-07 |
| Normal-vs-Age(81-100Yrs) |
3.922000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.797200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.768600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.962600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.284400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.884300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.665200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.974200E-01 |
| Normal-VS-Type2 PRCC |
8.86759998763864E-10 |
| Normal-VS-KIRP CIMP |
2.17350026865404E-10 |
| Normal-VS-Unclassified PRCC |
2.843800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.238180E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.90124999999153E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.707600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.472200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.948300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.563100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.75919999999952E-05 |
| Normal-vs-N1 |
6.692200E-01 |
| Normal-vs-N2 |
8.202200E-02 |
| N0-vs-N1 |
3.222200E-01 |
| N0-vs-N2 |
3.505400E-01 |
| N1-vs-N2 |
1.902570E-01 |
|
|
